Epidarex Capital

Epidarex Capital Creates Nodthera Limited

Edinburgh, Scotland, UK, July 28, 2016 --  Epidarex Capital today announces the launch of Nodthera Limited, a new biotech company focused on the discovery and development of novel inhibitors of the NLRP3 inflammasome. Nodthera is based on world class research conducted within Selvita S.A. ('Selvita'), an international drug discovery company, with offices in Boston, San...
20 Charlotte Square, Edinburgh, United Kingdom, EH2 4DF

+44 131 243 3700